XML 44 R20.htm IDEA: XBRL DOCUMENT v3.7.0.1

Note 1 - Nature of the Business Group Internal Restructuring (Tables)

12 Months Ended

Dec. 31, 2016

Notes Tables

Schedule of Subsidiaries [Table Text Block]

Name of company		Place of incorporation		Date of incorporation		Percentage of ownership by the Company		Principal activities
BeyondSpring Pharmaceuticals Inc. (“BeyondSpring US”)		Delaware, United States of America (“U.S.”)		June 18, 2013		100%		Clinical trial activities
BeyondSpring Ltd.		The British Virgin Islands (“BVI”)		December 3, 2014		100%		Holding company
BeyondSpring (HK) Limited (“BeyondSpring HK”)		Hong Kong		January 13, 2015		100%		Holding company
Wanchun Biotechnology Limited (“BVI Biotech”)		BVI		April 1, 2015		100%		Holding company
Wanchun Biotechnology (Shenzhen) Ltd. (“Wanchun Shenzhen”)		The People’s Republic of China (“PRC”)		April 23, 2015		100%		Holding company
Dalian Wanchunbulin Pharmaceuticals Ltd. (“Wanchunbulin”)		PRC		May 6, 2015		60%		Clinical trial activities
BeyondSpring Pharmaceuticals Australia PTY Ltd. (“BeyondSpring Australia”)		Australia		March 3, 2016		100%		Clinical trial activities

X

- Definition

A tabular disclosure of ownership percentage of subsidiaries of the company.

+ References

No definition available.

+ Details

Name:	bysi_ScheduleOfSubsidiariesTableTextBlock
Namespace Prefix:	bysi_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_TableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration